Altesa BioSciences

College Park, GA · Founded 2020 · Privately Held (backing)

Developer of antiviral medicines designed for the treatment of respiratory infections and global viral threats. Altesa BioSciences is based in College Park, GA and was founded in 2020. It was valued at $190 million at its later-stage round in Feb 2026, the last priced event on record. It has raised $114 million across 2 recorded rounds; the latest was a $75 million later-stage round in Feb 2026.

PMV mark · valuation
$190.0M
Oct 2026
Priced at
its later-stage round
Feb 2026
Total raised
$114.0M
Last round
Later Stage VC
Feb 2026
What is Altesa BioSciences worth?
$190.0MPrivateMarketView mark · Oct 2026

Valued at $190.0M at its later-stage round, Feb 2026. Nothing has traded since.

Free account
More of Altesa BioSciences with a free account
  • ·Watch Altesa BioSciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Altesa BioSciences funding history

2 rounds
DateRoundRaisedPost-money
Feb 2026Later Stage VC$75.0M▮
Dec 2022Early Stage VC$35.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Altesa BioSciences valuation

Altesa BioSciences was valued at $190 million at its later-stage round in Feb 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Altesa BioSciences raised?

Altesa BioSciences has raised $114 million across 2 recorded rounds since 2022. The largest was a $75 million later-stage round in Feb 2026.

Altesa BioSciences has filed 2 Form Ds with the SEC, most recently in Jul 2023 ($35 million sold to 18 investors).

How Altesa BioSciences's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Altesa BioSciences, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Altesa BioSciences

What is Altesa BioSciences worth?
Altesa BioSciences is valued at $190.0M as of Oct 2026. Valued at $190.0M at its later-stage round, Feb 2026. Nothing has traded since.
How much has Altesa BioSciences raised?
Altesa BioSciences has raised $114.0M in total funding across 2 recorded rounds.
When did Altesa BioSciences last raise?
Altesa BioSciences last raised in Feb 2026 (Later Stage VC), raising $75.0M.